B&G Foods (BGS) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
Fourth quarter and full year 2024 results were in line or slightly above expectations, with sequential improvement over prior quarters, despite ongoing softness in consumer demand and the impact of the Green Giant U.S. shelf-stable divestiture.
Base business net sales, excluding Crisco, decreased by only 0.4% year-over-year, showing improvement from earlier quarters.
The Spices & Flavor Solutions unit led sales growth, up 5% year-over-year in Q4.
Fiscal 2024 was challenging due to consumer adjustments to elevated food prices, with base business net sales down 3.3% year-over-year.
Transitioned from a single segment to four business segments: Specialty, Meals, Frozen & Vegetables, and Spices & Flavor Solutions.
Financial highlights
Q4 2024 net sales: $551.6 million; net loss: $222.4 million; adjusted net income: $24.6 million ($0.31/share); adjusted EBITDA: $86.1 million (15.6% of net sales).
FY 2024 net sales: $1.932 billion; net loss: $251.3 million; adjusted net income: $55.7 million ($0.70/share); adjusted EBITDA: $295.4 million (15.3% of net sales).
Q4 adjusted gross profit margin improved to 22.2% from 21.9% year-over-year.
Net sales for Q4 decreased 4.6% year-over-year, mainly due to divestitures and lower volumes.
Adjusted net income for Q4 2024 was $24.6M, up 4.6% year-over-year; full year adjusted net income was $55.7M, down 24.6%.
Outlook and guidance
FY 2025 net sales projected at $1.89–$1.95 billion, with adjusted EBITDA of $290–$300 million and adjusted EPS of $0.65–$0.75.
Expectation of lower sales in H1 2025, with improvement in H2 as consumer behavior laps inflationary impacts.
Guidance assumes status quo on tariffs and no major inflation upticks.
53rd week in FY 2025 expected to add $10–$15 million in net sales.
Latest events from B&G Foods
- Divestitures and margin gains shape 2025 results, with cautious guidance for 2026.BGS
Q4 20259 Jul 2026 - Q1 2025 net sales fell 10.5% and guidance was lowered as cost cuts and portfolio changes accelerate.BGS
Q1 20259 Jul 2026 - Q3 2024 net sales fell 8.3% to $461.1M, with lower guidance and ongoing margin pressures.BGS
Q3 20248 Jul 2026 - Portfolio reshaping led to higher base sales, a net loss, and a 50% dividend cut.BGS
Q1 202613 May 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the 2026 virtual meeting.BGS
Proxy filing3 Apr 2026 - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy filing3 Apr 2026 - Q2 sales fell 5.3%, goodwill impairment hit results, and guidance was revised lower.BGS
Q2 20242 Feb 2026 - Portfolio reshaping and operational improvements target margin recovery and 2024 growth.BGS
Barclays 17th Annual Global Consumer Staples Conference22 Jan 2026 - Portfolio streamlining and cost initiatives aim to boost margins and enable future growth.BGS
Barclays 18th Annual Global Consumer Staples Conference 202531 Dec 2025